Voyager Biomedical, Inc. is committed to improving the lives of dialysis patients through the development of a novel vascular access device known as the ARK. The ARK has been designed to facilitate targeted needle placement and strengthen the vein by serving as a supportive exoskeleton. In addition, the ARK will increase patient comfort, and reduce stress and increase efficiency for caregivers, while benefiting the payer system by decreasing the surgeries necessary to enable long-term vascular access.

Huzhou Annov Medical Technology Co., Ltd., established on 2019-12-05, The scope of business includes the second category,Class III Medical Devices,Technology development in the field of biotechnology,technical consulting,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Venova Medical develops vascular access systems for patients requiring renal replacement therapy. It addresses patient level and system barriers for access creation while simultaneously providing quickly functioning access with less need for intervention. The company was founded in 2018 and is headquartered in Los Gatos, California.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Shanghai Jiaqi Biotechnology Suzhou Co., Ltd., established on 2016-11-29, Business scope includes biotechnology research and development;Technology development in the field of medical devices,technology transfer,technical consulting,Technical Services;Production of Medical Devices,Sales and import and export business;Own house rental,Property Management Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Mechanical Parts,Parts processing;Mechanical Parts,Parts sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures. The company's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. These products enable physicians to perform better, faster, and safer vascular occlusion procedures. The company was founded in 2011 and is based in Olathe, Kansas.

BioSurfaces is a provider of medical care services intended to be offered by augmenting existing and emerging medical approaches with nanotechnology. The company's services applies room-temperature electrospinning process to allow drug loading into each fiber, providing a reservoir for sustained drug release at the implant site, enabling customers to make devices and coatings as thin as 10um which can treat diseases at site.

Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Fort Mill, SC.

Avenu Medical is a medical device company that is dedicated to creating a paradigm shift in vascular access for hemodialysis patients. It focuses to pursue unmet clinical needs by developing a minimally invasive, cost-effective, and efficient approach to vascular access. Founded in 2010, it has developed the Ellipsys Vascular Access System, an innovative, image-guided, single catheter system used to percutaneously create an arteriovenous (AV) fistula for hemodialysis access (EndoAVF).

Fresenius Medical Care is a provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1.89 million individuals worldwide. It has a network of 2,716 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. It offers specialty pharmacy and laboratory services and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Bad Homburg, Frankfurt.

Jiangsu bioda Life Science is engaged in the R&D of implantable artificial medical products. This includes artificial blood vessels, providing surgeons with high-quality medical devices. The company was founded in 2015 and is based in Nantong, Jiangsu, China.

Fo Shan Shi Shun De Qu Mei Rui Kang Yang Ke Ji You Xian Gong Si, established on 2023-04-18, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;business training(Does not include education and training,Vocational skills training and other licensed training);Health Consulting Services(Does not include medical services);Remote Health Management Services;Rehabilitation assistive device fitting service;Information Consulting Service(Not including licensing information consulting services).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Flow Forward Medical develops vascular access sites designed to improve post-surgery success rates. The Arteriovenous Fistula Eligibility (AFE) System is a small, temporary, external blood pump designed to stimulate flow-mediated dilation to make more patients eligible for arteriovenous fistula (AVF) and increase success rates after surgery. The establishment of a reliable AVF reduces morbidity and mortality in hemodialysis patients, as well as the overall cost of care. The company was founded in 2014 by Frank Nicholas Franano and is headquartered in Olathe, Kansas.

Beijing Honghai Technology Development Co., Ltd., established on 2015-09-11, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Sell ​​metal materials,building materials,Equipment;Commissioned production and processing of medical devices;Import and export;Technology Import and Export;Agent import and export;Engaged in the production and development of interventional medical devices and oral medical materials.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Three Rivers Medical, Inc. provides health care services. The company is headquartered in Mountain View, CA.

Emodial is a medical equipment manufacturing company that produces and supplies series of dialysis devices.

Advanced BioHealing is an industry leader in the science of regenerative medicine. The Company is focused on the commercialization of cell-based and tissue-engineered products. It currently markets the FDA-approved product Dermagraft®, for diabetic foot ulcers. Additionally, the Company's development pipeline includes a next-generation bioengineered tissue product which is in clinical trials. ABH is a privately held company with research & development offices in New York, NY and manufacturing operations in La Jolla, CA.